Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Mkt Cap
Market Capitalization
₹780Cr
Rev Gr TTM
Revenue Growth TTM
19.70%
Peer Comparison
Compare up to 10 companies side by side across valuation, profitability, and growth.

DENTALKART
VS
| Quarter | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|
|
Growth YoY Revenue Growth YoY% | | | | | 45.9 | 70.7 | 28.1 | 13.0 | 22.8 | 14.8 |
| 37 | 33 | 49 | 49 | 53 | 57 | 67 | 57 | 67 | 70 |
Operating Profit Operating ProfitCr |
| 8.8 | 9.4 | 14.3 | 8.6 | 10.8 | 8.8 | 8.8 | 5.0 | 8.0 | 2.4 |
Other Income Other IncomeCr | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 1 | 1 |
Interest Expense Interest ExpenseCr | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Depreciation DepreciationCr | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 1 |
| 4 | 3 | 8 | 5 | 7 | 5 | 6 | 4 | 6 | 2 |
| 1 | 1 | 2 | 1 | 2 | 2 | 2 | 1 | 1 | 1 |
|
Growth YoY PAT Growth YoY% | | | | | 44.0 | 63.1 | -34.8 | -21.5 | -13.6 | -66.3 |
| 9.2 | 6.6 | 11.1 | 6.3 | 9.0 | 6.3 | 5.7 | 4.4 | 6.4 | 1.9 |
| 2.4 | 1.5 | 4.0 | 2.1 | 3.4 | 2.5 | 2.5 | 1.6 | 2.8 | 0.8 |
| Financial Year | Mar 2024 | Mar 2025 | TTM |
|---|
|
| | 45.1 | 11.7 |
| 153 | 226 | 262 |
Operating Profit Operating ProfitCr |
| 11.1 | 9.2 | 6.1 |
Other Income Other IncomeCr | 1 | 2 | 3 |
Interest Expense Interest ExpenseCr | 0 | 0 | 0 |
Depreciation DepreciationCr | 1 | 2 | 2 |
| 19 | 23 | 18 |
| 4 | 6 | 5 |
|
| | 12.1 | -24.3 |
| 8.8 | 6.8 | 4.6 |
| 9.7 | 10.4 | 7.8 |
| Financial Year | Mar 2024 | Mar 2025 | Sep 2025 |
|---|
Equity Capital Equity CapitalCr | 16 | 17 | 17 |
| 52 | 103 | 153 |
Current Liabilities Current LiabilitiesCr | 16 | 17 | 19 |
Non Current Liabilities Non Current LiabilitiesCr | 1 | 1 | 1 |
Total Liabilities Total LiabilitiesCr |
Current Assets Current AssetsCr | 81 | 126 | 162 |
Non Current Assets Non Current AssetsCr | 4 | 25 | 29 |
Total Assets Total AssetsCr |
| Financial Year | Mar 2024 | Mar 2025 |
|---|
Operating Cash Flow Operating Cash FlowCr | -11 | -4 |
Investing Cash Flow Investing Cash FlowCr | -22 | -43 |
Financing Cash Flow Financing Cash FlowCr | 36 | 47 |
|
Free Cash Flow Free Cash FlowCr | -14 | -24 |
| -75.9 | -21.0 |
CFO To EBITDA CFO To EBITDA% | -60.1 | -15.5 |
| Financial Year | Mar 2024 | Mar 2025 |
|---|
Valuation Ratios Valuation Ratios |
Market Cap Market CapitalizationCr | 785 | 1,037 |
Price To Earnings Price To Earnings | 13.0 | 61.1 |
Price To Sales Price To Sales | 4.6 | 4.2 |
Price To Book Price To Book | 11.5 | 8.6 |
| 40.5 | 45.0 |
Profitability Ratios Profitability Ratios |
| 27.0 | 29.8 |
| 11.1 | 9.2 |
| 8.8 | 6.8 |
| 28.5 | 19.3 |
| 22.1 | 14.1 |
| 17.6 | 11.2 |
Operational Ratios Operational Ratios |
Solvency Ratios Solvency Ratios |
Liquidity Ratios Liquidity Ratios |
### **Overview**
Vasa Denticity Limited is an Indian dental technology and distribution company operating primarily under the brand **Dentalkart.com**, a comprehensive B2B e-commerce platform serving dental professionals across India. With a vision to build an Indian equivalent of the global Henry Schein model, the company is establishing itself as a **full-stack dental ecosystem**—integrating digital platforms, supply chain infrastructure, clinical support, lab services, and education into a unified offering for dentists.
As of November 2025, Vasa Denticity is executing an aggressive long-term strategy focused on **operational scale, vertical integration, and market consolidation**, reinforced by strategic acquisitions, technology investments, and expansion into high-growth segments like dental labs and digital dentistry.
---
### **Recent Milestones (as of Aug–Oct 2025)**
1. **Acquisition of IDS Denmed (51% Stake):**
- IDS Denmed is India’s largest offline dental distributor, with over 2,000 dealers and a 30-year presence, especially strong in Tier 2/3 towns and rural areas.
- The acquisition combines Dentalkart’s tech-first platform with IDS Denmed’s extensive **offline dealer network**, creating **India’s largest integrated dental supply chain**, reaching over 90% of dental clinics.
- Synergies expected in procurement, warehousing, faster deliveries, and expanded reach for high-end equipment and consumables.
- Transaction subject to regulatory and shareholder approvals.
2. **Launch of Smileworks Lab:**
- A state-of-the-art, company-owned **dental laboratory** producing crowns, bridges, aligners, implants, and custom prosthetics using digital CAD/CAM systems and automated workflows.
- Already contributing to revenue with month-on-month growth and approaching break-even.
- Seamlessly integrated into Dentalkart’s ecosystem for real-time tracking and fast fulfillment.
- Targets ₹50+ crore in long-term revenue.
3. **International Expansion:**
- Established **Dentalkart Distribution UK Limited**, a UK-based subsidiary to enter European markets.
- Focus on expanding distribution of proprietary and partner products into the UK and neighboring regions.
4. **Waldent Innovations:**
- Wholly owned subsidiary manufacturing and distributing surgical instruments, diagnostic devices, and premium equipment.
- Active in industry events and training programs to engage clinicians.
---
### **Core Business Model & Differentiators**
| **Aspect** | **Details** |
|-----------|-----------|
| **Platform** | Dentalkart.com – India’s most comprehensive dental commerce platform, serving **over 105,000 dentists** (as of Oct 2025), with 4.8L+ monthly active users. |
| **Product Range** | Over **22,468 SKUs** (as of May 2025), including consumables, instruments, equipment, and digital solutions. Portfolio expanded by 4,000+ SKUs post-IDS Denmed integration. |
| **Private Labels** | ≈50% of sales driven by **45+ proprietary brands**; priced 3–5% lower than competitors due to direct manufacturer procurement. |
| **Revenue Mix** | Dominated by **consumables**, but increasing focus on **equipment and lab products** to drive bundled sales and higher wallet share. |
| **Technology Stack** | Fully migrated or nearing **microservices architecture**, enhanced mobile/web apps, real-time tracking, AI-based search, and automated workflows. |
---
### **Operational & Logistics Infrastructure**
- **Warehousing:**
- Total footprint expanded to **~58,000 sq. ft.** across 12+ locations, including a new **13,875 sq. ft. central warehouse near Delhi Airport**.
- Goals: Sub-48-hour delivery pan-India; same-day in Tier I cities.
- **Delivery Performance:**
- Average delivery time improved to **3.8 days** (from 4+ days), targeting **under 3 days**.
- Integration with courier partners like Blue Dart, FedEx, Shipyaari; dynamic routing via pin code analytics.
- **Inventory Strategy:**
- High inventory levels maintained to ensure availability and build trust.
- Investment in **automated forecasting**, machine learning, and RTV (return-to-vendor) agreements to optimize stock and reduce obsolescence.
- Target: Expand catalog to **35,000 SKUs**, benchmarked against Henry Schein’s 35,000+.
---
### **Expansion into Digital Dentistry & Innovation**
- **Product Offerings:**
- Intraoral scanners: IntraVue 900Ai (sub-₹200k) and premium 3Shape TRIOS.
- 3D Printers: Bundled free with high-value items (e.g., scanners) to stimulate digital workflow adoption.
- Partnerships: ELEGOO, ARMA Dental, CREALITY (resins & printers); JINY CAD/CAM, Fast Form (metal 3D printing), BLZ (scanners).
- **AI & Software:**
- **VASA Dental Cloud Platform**: Unified digital suite integrating clinical, lab, and business workflows.
- Free **AI-driven design suite** for crown, splint, and model design.
- Development of practice management tools and AI-assisted diagnostics.
- **Digital Penetration Goal:** Increase digital dentistry adoption in India from **4% to 40%**, aligned with global trends.
---
### **Market Position & Growth Strategy**
- **No Direct Peers:** Dentalkart has **no comparable online competitor** in scale or ecosystem depth in India.
- **Customer Access:** Primary destination for nearly all dentists for product research and pricing.
- Challenge: Converting traffic into **higher wallet share**.
- Strategy: Improve delivery speed, returns, and product availability.
- **Geographic Reach:**
- Strong presence in **Tier 2/3 cities**, where it serves as a primary supplier.
- In Tier 1, competing on **breadth and reliability** vs. local distributors offering speed but limited SKUs.
- **Offline-Online Integration:**
- Leveraging IDS Denmed’s **12 Tier I city warehouses** and 2,000-dealer network for last-mile delivery and service support.
- Plans to launch **company-owned service centers** in major cities for equipment repairs.
---
### **Customer Engagement & Education**
- **B2B Marketing:**
- Targeted social media campaigns on Instagram for dentists; reported **94 lakh cumulative impressions** (not unique users) in professional segment.
- Low marketing spend (<2% of revenue), but planned increase for customer acquisition.
- **Continuing Education:**
- Developing a **digital CDE (Continuing Dental Education) platform** to help dentists find and book accredited events.
- Engages through webinars, peer forums, and partnerships with 12 dental universities.
- **KOL Network:**
- Led by **Dr. Akanksha Aggarwal** (Non-Executive Director) and other leading practitioners; guides product development and clinical validation.
---
### **Financials & Performance (FY2024–25)**
- **Revenue:** ₹251.3 crore (**+45% YoY growth**)
- **EBITDA:** ₹24.9 crore
- **Net Profit:** ₹16.9 crore
- **Repeat Customers:** 60–70% repeat purchase rate across platforms.
- **Margins:** Temporarily pressured due to **strategic investments** in warehouses, tech upgrades, and inventory, but expected to improve post-stabilization.
---
### **Leadership & Governance**
- **Dr. Vikas Agarwal**: Founder, Chairman & Managing Director. Dental surgeon (Maulana Azad Institute), technical visionary behind core product strategy.
- **Dr. Akanksha Aggarwal**: Non-Executive Director, provides clinical and product development guidance.
- Founders of acquired Smileworks Lab (Dr. Ankur Gupta & Mr. Lalit Sharma) hold 40% stake, continuing as partners.
---
### **Challenges & Strategic Priorities**
1. **Delivery Speed:** Local distributors in Tier 1 cities offer faster turnaround on in-stock items; Dentalkart must close the gap while maintaining breadth.
2. **Wallet Share:** High visibility doesn’t yet translate to primary supplier status for many dentists.
3. **Operational Transition:** Deliberate slowing of growth in 2024–25 to strengthen backend (warehouses, tech, teams); impacts short-term conversion but builds long-term scalability.
4. **Cost Control:** Warehousing and logistics are #2 and #3 cost centers; investments continue despite margin pressure.